№ lp_1_02711
File format: docx
Character count: 5660
File size: 94 KB
Year:
2023
Note:
Region / City
Subject:
Billing Requirements for Drugs and Biologicals with Discarded Amounts
Document Type:
Policy
Organization / Institution:
SummaCare, Apex Summa Health Management Company, Summa Insurance Company
Target Audience:
Providers, Healthcare Administrators, Claims Department
Effective Period:
From 01/01/2017
Approval Date:
08/15/2023
Review Date:
Every 2 years or as necessary
Compliance Statement:
All members of the workforce are responsible for compliance with this policy.
Monitoring and Auditing:
Claims Department
Documentation Retention:
Minimum of 10 years
Purpose:
To outline the billing requirements for drugs and biologicals with unused and discarded amounts from single-dose containers or single-use packages.
Description:
Guidelines on proper billing procedures for drugs and biologicals, including the use of JW and JZ modifiers for discarded drug amounts or no wastage in single-dose vials, applicable to providers and insurers.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / City:
USA
Subject:
Medicare Part B Drugs and Biologicals ASP Data Reporting
Document Type:
Regulatory
Organization / Institution:
Centers for Medicare & Medicaid Services (CMS)
Author:
Centers for Medicare & Medicaid Services (CMS)
Target Audience:
Manufacturers of Medicare Part B Drugs and Biologicals
Period of Effect:
From January 1, 2022
Approval Date:
Not specified
Amendment Date:
November 5, 2025
Year:
2022
Region / city:
Australia
Topic:
Therapeutic Goods Regulation
Document type:
Guidance
Organization:
Therapeutic Goods Administration (TGA)
Author:
Commonwealth of Australia
Target audience:
Sponsors, manufacturers, and regulatory professionals
Validity period:
Not specified
Approval date:
October 2022
Date of changes:
Not specified
Year:
2021
Jurisdiction:
Australia
Document type:
Regulatory order
Subject:
Standards for biological therapeutic goods
Authority:
Minister for Health and Aged Care
Responsible body:
Department of Health
Commencement date:
30 September 2021
Scope:
Human musculoskeletal, cardiovascular, ocular, skin, and amnion tissue products
Legal basis:
Therapeutic Goods Act 1989
Status:
Draft at the time of excerpt, not for signature
Year:
2021
Region / City:
Australia
Subject:
Biologicals, Labelling Requirements
Document Type:
Regulatory Guidelines
Organization / Institution:
Therapeutic Goods Administration (TGA)
Author:
Therapeutic Goods Administration (TGA)
Target Audience:
Manufacturers and sponsors of biologicals
Effective Period:
From 30 September 2021
Approval Date:
May 2021
Revision Date:
Not specified
Note:
Year
Note:
Year
Context:
This is a technical document detailing the specifications and compliance checks for prime movers, including information about engine and vehicle components, modifications, and their compliance with safety and regulatory standards.
Year:
2026
Region / City:
United States, California
Topic:
Healthcare Billing Procedures
Document Type:
Instructional Guide
Organization / Agency:
California Department of Alcohol and Drug Programs
Author:
Internal Documentation Team
Target Audience:
Healthcare billing staff and administrators
Applicable Period:
2026
Date of Approval:
2026-02-01
Procedure Type:
Contingency Management Service Billing
Platform:
Medi-Cal, Commercial Insurance, Medicare
Note:
Year
Year:
Not specified
Region / City:
Not specified
Document type:
Technical and compliance report
Vehicle make:
Not specified
Vehicle model:
Not specified
Month and year of manufacture:
Not specified
VIN:
Not specified
Vehicle chassis number:
Not specified
Vehicle modifier:
Not specified
Examiner / certifying authority:
AVE
S12 design certificate number:
Not specified
Axle configuration:
Front and rear axle groups
Brake system details:
Included, with calculated braking performance and ERC deceleration
Tow couplings:
Front and rear specified with D-rating
Tyre size and suspension:
Detailed per component
Compliance with standards:
ADR 38/.., ADR 62/..
Modification assessment:
Yes/No/N/A checklist for ATM, GTM, chassis construction, braking, and certification
Authorisation:
Certificate signed by certifying authority with modification certificate number
Year:
2026
Region / City:
Gothenburg, Sweden
Topic:
Vehicle accessibility and adaptation
Document type:
Press release
Organization:
BraunAbility Europe
Parent company:
Investor’s Patricia Industries
Vehicles covered:
Ford Transit V363, Ford Custom V362
Certification:
Ford Qualified Vehicle Modifier (QVM)
Global presence:
USA, Sweden, Denmark, UK, over 60 countries
Employees:
over 1,400
Key personnel:
Stefan Larsson, Tobias Hägg
Industry recognition:
accredited testing centre, pioneer in safety and quality
Year:
2017
Region / City:
Not specified
Subject:
Healthcare claims processing
Document Type:
Policy update
Organization:
Healthcare payer systems
Author:
Not specified
Target Audience:
Healthcare providers, billing professionals
Period of Validity:
September 1, 2017 onward
Date of Approval:
September 1, 2017
Date of Changes:
September 1, 2017
Note:
Contextual description
Year:
2025
Region / City:
Not specified
Theme:
Healthcare, Drug Coverage
Document Type:
Informational Flyer
Organization / Institution:
Wellcare
Author:
Not specified
Target Audience:
Healthcare providers, insurance plan members
Period of Validity:
Not specified
Approval Date:
07/24/2024
Date of Changes:
Not specified
Year:
2021
Region / City:
Australia
Theme:
Mental health, Alcohol and Other Drugs
Document Type:
Unit of competency
Organization / Institution:
Australian Skills Quality Authority (ASQA)
Author:
Not specified
Target Audience:
People working in community services, mental health and alcohol and other drug sectors
Period of validity:
Not specified
Approval Date:
Not specified
Date of modifications:
Release 2, Modification History: Release 2
Note:
Year
Topic:
Clinical Trial Agreement
Document Type:
Contract
Institution / Organization:
Istituto clinico Humanitas
Target Audience:
Medical, Scientific, and Research Professionals
Unit code:
CHCAOD007
Release:
2
Type:
Competency unit
Sector:
Health and community services
Target group:
Workers supporting people with alcohol and other drug challenges
Application:
Relapse prevention and management strategies
Legislation and standards:
Commonwealth and State/Territory legislation, Australian/New Zealand standards, industry codes of practice
Skills:
Relapse prevention planning, risk assessment, harm minimisation, communication, crisis management
Assessment:
Workplace demonstration or simulated environment, treatment plans, risk assessment tools
Knowledge:
Legal and ethical considerations, AOD effects and responses, relapse triggers, support strategies, therapy options, environmental and individual risk factors
Year:
2023
Region:
Scotland
Jurisdiction:
Scotland
Topic:
Management of controlled drugs in primary care
Document type:
Guidance
Version:
3.0
Publication date:
April 2023
Issuing body:
Controlled Drugs Accountable Officers’ Network Scotland
Contributing organisation:
NHS Dumfries & Galloway
Foreword author:
Graeme Bryson
Author role:
Director of Pharmacy
Target audience:
Practitioners working within primary care
Legal framework referenced:
Misuse of Drugs Act 1971; Misuse of Drugs Regulations 2001; Controlled Drugs (Supervision of Management and Use) Regulations 2013
Scope:
Prescribing, supply, administration, storage, recording, monitoring and destruction of controlled drugs
Source type:
Official professional guidance
Note:
Year
Topic:
Incident Reporting
Document Type:
Report Form
Organization:
NHS
Target Audience:
NHS Staff, Contractors
Year:
2023
Region / City:
Southwest London
Theme:
Pharmaceutical Offers, Medicines Access
Document Type:
Template
Organization / Institution:
Southwest London Integrated Care System (SWL ICS)
Author:
Southwest London ICS Pharmacy Team
Target Audience:
Healthcare Professionals, Pharmacists, Medical Staff
Action Period:
Ongoing
Approval Date:
2023-10-01
Amendment Date:
N/A
Contextual Description:
A template outlining procedures for Southwest London Trusts to request approval for commercial offers and deeply discounted medicines, including "Free of Charge" (FOC) schemes based on RMOC guidelines.
Year:
2012
Region / City:
Morgan County, Georgia
Topic:
Legal procedure, DUI test evidence
Document type:
Court brief
Organ / Institution:
Superior Court of Morgan County, Georgia
Author:
N/A
Target Audience:
Legal professionals, court officials
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A